Influence of Peak Inspiratory Flow Rates and Pressure Drops on Inhalation Performance of Dry Powder Inhalers

被引:16
|
作者
Hira, Daiki [1 ]
Okuda, Tomoyuki [1 ]
Ichihashi, Mika [1 ]
Mizutani, Ayano [1 ]
Ishizeki, Kazunori [2 ]
Okada, Toyoko [2 ]
Okamoto, Hirokazu [1 ]
机构
[1] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan
[2] Hitachi Automot Syst Ltd, Gunma 3720023, Japan
关键词
dry powder inhaler; inhalation device; inspiratory flow rate; human inspiratory flow simulator; powder formulation; STANDARDIZED ENTRAINMENT TUBES; COMPUTATIONAL FLUID-DYNAMICS; IN-VITRO; DRUG-DELIVERY; LACTOSE; FORMULATION; DESIGN; BLENDS; MONOHYDRATE; RESISTANCE;
D O I
10.1248/cpb.60.341
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to reveal the relationship between human inspiratory flow patterns and the concomitant drops in pressure in different inhalation devices, and the influence of the devices on inhalation performance. As a model formulation for inhalers, a physically mixed dry powder composed of salbutamol sulfate and coarse lactose monohydrate was selected. The drops in pressure at 28.3 L/min of three inhalation devices, Single-type, Dual-type, and Reverse-type, was 1.0, 5.1, and 8.7 kPa, respectively. Measurements of human inspiratory patterns revealed that although the least resistant device (Single) had large inter- and intra-individual variation of peak flow rate (PFR), the coefficients of variation of PFR of the three devices were almost the same. In tests with a human inspiratory flow simulator in vitro, inhalation performance was higher, but the variation in inhalation performance in the range of human flow patterns was wider, for the more resistant device. To minimize the intra- and inter-individual variation in inhalation performance for the model formulation in this study, a formulation design that allows active pharmaceutical ingredient to detach from the carrier with a lower inhalation flow rate is needed.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 50 条
  • [21] In Vitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator
    Hira, Daiki
    Okuda, Tomoyuki
    Mizutani, Ayano
    Tomida, Nao
    Okamoto, Hirokazu
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (06) : 1731 - 1735
  • [22] Influence of physical properties of carrier on the performance of dry powder inhalers
    Peng, Tingting
    Lin, Shiqi
    Niu, Boyi
    Wang, Xinyi
    Huang, Ying
    Zhang, Xuejuan
    Li, Ge
    Pan, Xin
    Wu, Chuanbin
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (04) : 308 - 318
  • [23] Influence of physical properties of carrier on the performance of dry powder inhalers
    Tingting Peng
    Shiqi Lin
    Boyi Niu
    Xinyi Wang
    Ying Huang
    Xuejuan Zhang
    Ge Li
    Xin Pan
    Chuanbin Wu
    Acta Pharmaceutica Sinica B, 2016, 6 (04) : 308 - 318
  • [24] Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients
    Jogi, Rain
    Julge, Kaja
    Samaruutel, Priit
    Raatikainen, Liisa
    Vanto, Timo
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [25] The intra-individual variability of inhalation rates through two different dry powder inhalers
    Tarsin, W
    Hawksworth, GM
    Chrystyn, H
    THORAX, 2000, 55 : A61 - A61
  • [26] In vitro testing of two formoterol dry powder inhalers at different flow rates
    Weuthen, T
    Roeder, S
    Brand, P
    Müllinger, B
    Scheuch, G
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2002, 15 (03): : 297 - 303
  • [27] Age-Dependent Deterioration of Peak Inspiratory Flow with Two Kinds of Dry Powder Corticosteroid Inhalers (DiskusR and TurbuhalerR) and Relationships with Asthma Control
    Baba, Kenji
    Tanaka, Hiroyuki
    Nishimura, Masaki
    Yokoe, Norihito
    Takahashi, Daisuke
    Yagi, Takeo
    Yamaguchi, Etsuro
    Maeda, Yuka
    Muto, Tatsuya
    Hasegawa, Takaaki
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2011, 24 (06) : 293 - 301
  • [28] Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements
    Magramane, Sabrina
    Vlahovic, Kristina
    Gordon, Peter
    Kallai-Szabo, Nikolett
    Zelko, Romana
    Antal, Istvan
    Farkas, Dora
    PHARMACEUTICALS, 2023, 16 (12)
  • [29] Peak inhalation rates (PIFRs) of COPD patients when using a metered dose inhaler (MDI) and recently introduced dry powder inhalers (DPI)
    Tarsin, W
    Alshowair, RAM
    Corrado, OJ
    Pearson, SB
    Chrystyn, H
    THORAX, 2003, 58 : 73 - 73
  • [30] Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases
    Ding, Nan
    Zhang, Wei
    Wang, Zhuo
    Bai, Chong
    He, Qian
    Dong, Yuchao
    Feng, Xiumin
    Zhang, Jingxi
    Gao, Shen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1913 - 1924